Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China
· Delayed Price · Currency is CNY 28.57
+0.72 (2.59%)
At close: Mar 10, 2026
Enwei Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Market Capitalization | 2,888 | 2,307 | 2,911 | 2,789 | - | - | Upgrade
|
| Market Cap Growth | 20.17% | -20.75% | 4.40% | - | - | - | Upgrade
|
| Enterprise Value | 2,555 | 2,014 | 2,403 | 2,225 | - | - | Upgrade
|
| Last Close Price | 28.57 | 22.66 | 26.98 | 24.89 | - | - | Upgrade
|
| PE Ratio | 54.82 | 61.53 | 33.73 | 41.13 | - | - | Upgrade
|
| PS Ratio | 3.25 | 2.84 | 3.71 | 4.03 | - | - | Upgrade
|
| PB Ratio | 2.66 | 2.18 | 2.64 | 2.42 | - | - | Upgrade
|
| P/TBV Ratio | 3.35 | 2.80 | 3.41 | 2.76 | - | - | Upgrade
|
| P/FCF Ratio | 87.81 | 80.43 | - | 71.88 | - | - | Upgrade
|
| P/OCF Ratio | 34.52 | 29.24 | 34.66 | 44.72 | - | - | Upgrade
|
| EV/Sales Ratio | 2.88 | 2.48 | 3.06 | 3.22 | - | - | Upgrade
|
| EV/EBITDA Ratio | 24.73 | 23.18 | 20.87 | 22.42 | - | - | Upgrade
|
| EV/EBIT Ratio | 51.51 | 47.96 | 29.89 | 32.57 | - | - | Upgrade
|
| EV/FCF Ratio | 77.69 | 70.19 | - | 57.35 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.19 | 0.00 | - | - | - | Upgrade
|
| Debt / EBITDA Ratio | 1.86 | 2.25 | 0.01 | - | - | - | Upgrade
|
| Debt / FCF Ratio | 5.84 | 6.90 | - | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.31 | -0.30 | -0.35 | -0.50 | -0.12 | -0.13 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.26 | -3.65 | -3.40 | -5.83 | -0.61 | -0.57 | Upgrade
|
| Net Debt / FCF Ratio | -10.12 | -11.05 | 7.83 | -14.90 | -1.59 | -1.63 | Upgrade
|
| Asset Turnover | 0.61 | 0.57 | 0.57 | 0.61 | 0.79 | 0.79 | Upgrade
|
| Inventory Turnover | 4.14 | 3.63 | 3.63 | 3.23 | 3.17 | 3.65 | Upgrade
|
| Quick Ratio | 3.76 | 3.42 | 3.16 | 3.64 | 1.38 | 1.29 | Upgrade
|
| Current Ratio | 4.44 | 3.99 | 3.75 | 4.21 | 2.08 | 1.75 | Upgrade
|
| Return on Equity (ROE) | 4.95% | 3.47% | 7.65% | 7.55% | 16.56% | 19.64% | Upgrade
|
| Return on Assets (ROA) | 2.12% | 1.85% | 3.66% | 3.75% | 7.25% | 8.12% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.38% | 4.64% | 10.64% | 9.94% | 15.87% | 18.61% | Upgrade
|
| Return on Capital Employed (ROCE) | 3.90% | 3.30% | 7.10% | 5.80% | 14.90% | 16.90% | Upgrade
|
| Earnings Yield | 1.80% | 1.63% | 2.96% | 2.43% | - | - | Upgrade
|
| FCF Yield | 1.14% | 1.24% | -1.72% | 1.39% | - | - | Upgrade
|
| Dividend Yield | 1.23% | 0.79% | 2.00% | 6.43% | - | - | Upgrade
|
| Payout Ratio | 40.97% | 151.90% | 130.02% | - | 45.22% | 1.52% | Upgrade
|
| Buyback Yield / Dilution | 1.90% | 1.82% | -21.93% | -8.34% | -6.51% | 6.12% | Upgrade
|
| Total Shareholder Return | 3.16% | 2.62% | -19.93% | -1.92% | -6.51% | 6.12% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.